Glyscend Therapeutics Appoints Sapan A. Shah, Ph.D., Accomplished Industry Executive, as Chief Executive Officer
Dr. Shah has more than 25 years of experience leading innovative life science companies as CEO, founder, board member and strategic advisor.
- Dr. Shah has more than 25 years of experience leading innovative life science companies as CEO, founder, board member and strategic advisor.
- In conjunction with the transition, founding CEO, Ashish Nimgaonkar, M.D., was appointed to the newly created role of Chief Medical Officer and Head of Research and Development.
- “I am thrilled to welcome Sapan to the team and excited to partner with him through the next phase of Glyscend’s growth.
- I look forward to working alongside the Glyscend team and Board to bring this important medicine to patients.”